8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
Abstract
Free of or salt forms of type (I) compounds, which R1 is hydrogen or any selected to is hydroxy, and n-oxygen base or n-sulfur base replaced of alkyl, R2 is hydrogen, and alkyl, and hydroxy alkyl, and alkyl Carbonyl oxygen base alkyl, and n-oxygen base alkyl, and n-sulfur base alkyl, and chain Ene base, and ring alkyl alkyl, and hybrid ring base alkyl, and Fong alkyl, by in Fong alkyl in the of Fong ring can any selected to and a 5 Yuan hybrid ring group heavy collection or any selected to is a or multiple selected since n-oxygen base, and amino, and alkyl amino, and II alkyl amino, and acyl amino, and halogen, and hydroxy, and Amino sulfonic acyl, and alkyl amino sulfonic acyl, and II alkyl amino sulfonic acyl, and alkyl sulfonic acyl amino or II alkyl amino sulfonic acyl amino of replaced base by replaced, R3 is hydrogen or any selected to is hydroxy, and n-oxygen base or n-sulfur base replaced of alkyl, R4 is hydrogen or alkyl, R5 is quinoline base, and different quinoline base or oxygen generation II hydrogen different quinoline base, these group any selected to and a 5 Yuan hybrid ring group heavy merged and any selected to is a or multiple selected since following of replaced base by replaced: Halogen, and cyanide base, and hydroxy, and alkyl, and hydroxy alkyl, and n-oxygen base alkyl , And n-sulfur base alkyl, and n-oxygen base, and n-sulfur base, and chain vinyl base, and n-oxygen base Carbonyl, and chain acetylene base, and carboxyl, and acyl, and type-N (R6) R7 of group, and any selected to was a or multiple selected since halogen or n-oxygen base of replaced base replaced of aryl, and or by ring carbon Atomic and specifies carbon Atomic connection of contains 5 or 6 a ring Atomic of miscellaneous aryl, R6 and R7 each other independent to is hydrogen or any selected to was hydroxy or n-oxygen base replaced of alkyl, or R6 and R7 in the has a is hydrogen and another is acyl, Or R6 and R7, and together, they are connected to a nitrogen Atom heterocyclic group of 5 or 6.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
59 members in 30 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 0008694 | United Kingdom | A | |
| 0103909 | European Patent Office (EPO) | W |
Members59
| Document | Office | Kind | |
|---|---|---|---|
| GB0008694D0 | United Kingdom | D0 | |
| CA2403514A1 | Canada | A1 | |
| WO0177110A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7392101A | Australia | A | |
| PE20020228A1 | Peru | A1 | |
| NO20024741D0 | Norway | D0 | |
| NO20024741L | Norway | L | |
| KR20020081590A | Republic of Korea | A | |
| EP1268480A1 | European Patent Office (EPO) | A1 | |
| CZ20023305A3 | Czechia | A3 | |
| MXPA02009903A | Mexico | A | |
| SK14282002A3 | Slovakia | A3 | |
| AR028531A1 | Argentina | A1 | |
| CN1420887A | China | A | |
| IL152078D0 | Israel | D0 | |
| BR0109855A | Brazil | A | |
| ZA200207956B | South Africa | B | |
| HU0300565A2 | Hungary | A2 | |
| HUP0300565A2 | Hungary | A2 | |
| US2003171384A1 | United States of America | A1 | |
| JP2003530398A | Japan | A | |
| EP1268480B1 | European Patent Office (EPO) | B1 | |
| AT253576TThis record | Austria | T | |
| ATE253576T1 | Austria | T1 | |
| DE60101158D1 | Germany | D1 | |
| US2004038996A1 | United States of America | A1 | |
| DK1268480T3 | Denmark | T3 | |
| TR200400185T4 | Türkiye | T4 | |
| RU2002129557A | Russian Federation | A | |
| PT1268480E | Portugal | E | |
| SI1268480T1 | Slovenia | T1 | |
| NZ521361A | New Zealand | A | |
| ES2210169T3 | Spain | T3 | |
| PL358205A1 | Poland | A1 | |
| DE60101158T2 | Germany | T2 | |
| HU0300565A3 | Hungary | A3 | |
| HUP0300565A3 | Hungary | A3 | |
| CN1176922C | China | C | |
| US2005054660A1 | United States of America | A1 | |
| MY119238A | Malaysia | A | |
| AU2001273921B2 | Australia | B2 | |
| US6919337B2 | United States of America | B2 | |
| KR100526094B1 | Republic of Korea | B1 | |
| RU2269529C2 | Russian Federation | C2 | |
| US2006047945A1 | United States of America | A1 | |
| WO2006026115A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US7019136B2 | United States of America | B2 | |
| US2006106214A1 | United States of America | A1 | |
| US2006173181A1 | United States of America | A1 | |
| JP3869725B2 | Japan | B2 | |
| EP1802624A2 | European Patent Office (EPO) | A2 | |
| JP2008511910A | Japan | A | |
| US7361661B2 | United States of America | B2 | |
| US7373492B2 | United States of America | B2 | |
| WO2006026115A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2403514C | Canada | C | |
| EP1802624A4 | European Patent Office (EPO) | A4 | |
| PL212407B1 | Poland | B1 | |
| JP5048498B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1940294
Titles2
- German
- 8-CHINOLINXANTHIN AND 8-ISOCHINOLINXANTHIN DERIVATE ALS PDE 5 INHIBITOREN
- English
- 8-CHINOLINXANTHIN AND 8-ISOCHINOLINXANTHINE DERIVATIVES AS PDE 5 INHIBITORS
Classification
- CPC, 27
- C07D239/545
- C07D473/06
- A61P1/00
- A61P1/04
- A61P1/14
- A61P9/00
- A61P9/04
- A61P9/10
- A61P9/12
- A61P11/06
- A61P11/08
- A61P13/02
- A61P13/08
- A61P13/10
- A61P15/00
- A61P15/08
- A61P15/10
- A61P17/00
- A61P17/06
- A61P17/14
- A61P25/00
- A61P25/28
- A61P27/02
- A61P27/06
- A61P27/16
- A61P35/04
- A61P43/00
- IPC, 25
- C07D473 04
- A61K31 52
- A61K31 5377
- A61P1 04
- A61P9 04
- A61P9 10
- A61P9 12
- A61P11 06
- A61P11 08
- A61P13 02
- A61P13 08
- A61P13 10
- A61P15 00
- A61P15 08
- A61P15 10
- A61P17 00
- A61P17 06
- A61P25 00
- A61P25 28
- A61P27 02
- A61P27 16
- A61P35 04
- C07D239 54
- C07D239 545
- C07D473 06